We are live on ! Find out more
SI

Sofinnova Investments Portfolio holdings

AUM $2.63B
1-Year Est. Return 117.41%
This Fund
S&P 500
This Quarter Est. Return
+0.58%
1 Year Est. Return
+117.41%
3 Year Est. Return
+428.82%
5 Year Est. Return
+748.21%
10 Year Est. Return
–
AUM
$1.66B
AUM Growth
-$16.4M
Cap. Flow
+$51.9M
Cap. Flow %
3.12%
Top 10 Hldgs %
60%
Holding
84
New
16
Increased
17
Reduced
16
Closed
20

Top Buys

Rank Stock Value
1
BOLT icon
Bolt Biotherapeutics
BOLT
+$89.6M
2
NXTC icon
NextCure
NXTC
+$32.2M
3
LLY icon
Eli Lilly
LLY
+$28.1M
4
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$27.3M
5
ALGN icon
Align Technology
ALGN
+$25.2M

Top Sells

Rank Stock Value
1
ASND icon
Ascendis Pharma A/S
ASND
+$89.4M
2
ABBV icon
AbbVie
ABBV
+$31.5M
3
AMGN icon
Amgen
AMGN
+$30M
4
UTHR icon
United Therapeutics
UTHR
+$22.2M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$14.4M

Sector Composition

Rank Sector Weight
1 Healthcare 93.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CALA
76
CALL
DELISTED
Calithera Biosciences, Inc
CALA
– –
-8,750
Closed -$860K
CALA
77
PUT
DELISTED
Calithera Biosciences, Inc
CALA
– –
-20,000
Closed -$1.96M
KDMN
78
DELISTED
Kadmon Holdings, Inc.
KDMN
– –
-228,893
Closed -$950K
GWPH
79
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-100,762
Closed -$11.6M
ZGNX
80
DELISTED
Zogenix, Inc.
ZGNX
– –
-89,579
Closed -$1.79M
1 2 3
4

Similar funds

WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $2.63B AUM 20.53% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
IA
Integrity Alliance Urbandale, Iowa $2.64B AUM 16.75% 1-Year Est. Return
WCA
Waratah Capital Advisors Toronto, Ontario, Canada $2.63B AUM 76.33% 1-Year Est. Return
ACM
Advance Capital Management Southfield, Michigan $2.64B AUM 13.57% 1-Year Est. Return
NIG
NFJ Investment Group Dallas, Texas $2.64B AUM 23.86% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Sofinnova Investments's Q1 2021 Portfolio in Review

As of Q1 2021, Sofinnova Investments held 84 positions worth $1.66B, down 0.98% from $1.68B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Sofinnova Investments deployed $51.9M of net new capital in Q1 2021, opening 16 new positions and adding to 17 existing holdings. Its largest new stake was Bolt Biotherapeutics: 137,722 shares worth $90.6M.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, up from 92% a quarter earlier.

On the sell side, the largest reduction was Ascendis Pharma A/S, an estimated $89.4M trimmed.

  • Sofinnova Investments's largest Q1 2021 buy was Bolt Biotherapeutics: 137,722 shares worth $90.6M.
  • Sofinnova Investments added most to Eli Lilly in Q1 2021, an estimated $28.1M increase.
  • Sofinnova Investments's biggest Q1 2021 reduction was Ascendis Pharma A/S, cutting an estimated $89.4M.
  • Sofinnova Investments fully exited AbbVie in Q1 2021, selling an estimated $31.5M.
  • Sofinnova Investments's ten largest holdings make up 60% of its $1.66B portfolio in Q1 2021.
  • Sofinnova Investments opened 16 new positions and closed 20 in Q1 2021.
  • Sofinnova Investments's portfolio value fell 0.98% quarter-over-quarter to $1.66B.

Based on Sofinnova Investments's 13F filing for Q1 2021, filed 14 May 2021.